Please login to the form below

Not currently logged in

Bruce Peacock joins Dicerna from Ophthotech

He is appointed to its board of directors and audit committee

edit-Bruce-Peacock_2014US-based biopharma company Dicerna Pharmaceuticals has appointed Bruce Peacock to its board of directors and audit committee.

He joins from Ophthotech where he served since 2010, most recently as its chief financial and business officer and prior to that, his previous roles include serving as chief operating officer of Cephalon and chief financial officer of Centocor.

Massachusetts-headquartered Dicerna develops RNAi-based therapeutics with a focus on the discovery and development of treatments for rare inherited diseases involving the liver and for cancers that are genetically defined.

Douglas Fambrough, CEO at Dicerna, said: “Bruce Peacock is a recognised leader in the biotech industry. With an impressive list of accomplishments in operations, management and business development, Bruce will be a terrific addition to our board.”

22nd September 2014

From: Research



Featured jobs

Subscribe to our email news alerts


Add my company
Redline Strategic

We are a healthcare consultancy, specialising in people and experiences. Using innovative research methods to capture the thoughts of real...

Latest intelligence

Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...